Silk road medical, inc. (SILK)
CashFlow / Yearly
Dec'19Dec'18
Cash flows from operating activities
Net loss

-52,415

-37,630

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense

712

517

Stock-based compensation expense

2,977

911

Change in fair value of redeemable convertible preferred stock warrant liability

21,030

11,906

Amortization of premium on investments

309

0

Amortization of debt discount and debt issuance costs

46

68

Amortization of right-of-use asset

582

-

Non-cash interest expense

672

1,555

Loss on disposal of property and equipment

0

-159

Change in provision for doubtful accounts receivable

23

-123

Provision for excess and obsolete inventories

118

23

Changes in assets and liabilities
Accounts receivable

2,241

446

Inventories

4,696

2,565

Prepaid expenses and other current assets

1,471

1,128

Other assets

-552

62

Accounts payable

615

-309

Accrued liabilities

4,964

5,023

Other liabilities

-769

406

Net cash used in operating activities

-29,610

-21,695

Cash flows from investing activities
Purchases of property and equipment

535

2,276

Proceeds from sale of property and equipment

0

6

Purchases of investments

69,421

0

Net cash used in investing activities

-69,956

-2,270

Cash flows from financing activities
Non-controlling interest

0

1

Proceeds from initial public offering, net of underwriting discount, commissions and offering costs paid

109,352

-233

Proceeds from long-term debt

0

15,000

Proceeds from issuance of common stock

2,590

656

Net cash provided by (used in) financing activities

113,757

15,424

Net change in cash, cash equivalents and restricted cash

14,191

-8,541

Supplemental disclosure of cash flow information
Cash paid for interest

4,234

2,738

Non-cash investing and financing activities:
Accounts payable and accrued liabilities for purchases of property and equipment

32

6

Landlord paid tenant improvements

0

794

Offering costs in accounts payable and accrued liabilities

0

717

Right-of-use asset obtained in exchange for lease obligation

3,982

-

Net exercise of redeemable convertible preferred stock warrants to preferred stock

37,121

0

Conversion of redeemable convertible preferred stock to common stock upon initial public offering

144,140

0

Redeemable Convertible Preferred Stock
Proceeds from exercise of redeemable convertible preferred stock warrants

1,784

0

Common stock warrants outstanding
Proceeds from exercise of warrants

31

0